Bifidobacteria possess inhibitory activity against dipeptidyl peptidase-IV

Letters in Applied Microbiology

Volumn 62, Issue 3, 2016, Pages 250-255

  Zeng, Z ^a   Luo, J Y ^a   Zuo, F L ^a   Yu, R ^a   Zhang, Y ^a   Ma, H Q ^a   Chen, S W ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bifidobacteria; Diabetes; Dipeptidyl peptidase IV; DPP IV inhibition; Probiotic

Indexed keywords

BACTERIA;

BIFIDOBACTERIUM; BIFIDOBACTERIUM STRAINS; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITION; INHIBITORY ACTIVITY; PROBIOTICS; PROPERTY; TYPE-2 DIABETES;

STRAIN;

DIPEPTIDYL PEPTIDASE IV; PROBIOTIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INCRETIN;

BACTERIUM; BIOACTIVITY; DIABETES; DRUG DEVELOPMENT; INHIBITION; PROBIOTICS; PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; ENZYME INHIBITION; FECES MICROFLORA; IN VITRO STUDY; NONHUMAN; DIABETES MELLITUS, TYPE 2; FECES; HUMAN; INFANT; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM;

BIFIDOBACTERIUM; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FECES; HUMANS; INCRETINS; INFANT; MOLECULAR SEQUENCE DATA; PROBIOTICS;

EID: 84958729886     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12510     Document Type: Article

References (38)

1. Abe, M., Akiyama, T., Umezawa, Y., Yamamoto, K., Nagai, M., Yamazaki, H., Ichikawa, Y. and Muraoka, Y. (2005) Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors. Bioorg Med Chem 13, 785-797.
2. Ahren, B., Holst, J.J., Martensson, H. and Balkan, B. (2000) Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Eur J Pharmacol 404, 239-245.
3. Boots, J.W.P. (2009) Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use. Patent 11/722, 667 (US 2009/ 0075904).
4. Deacon, C.F. (2011) Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review. Diabetes Obes Metab 13, 7-18.
5. Diamant, M., Blaak, E.E. and de Vos, W.M. (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12, 272-281.
6. Drucker, D.J. and Nauck, M.A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705.
7. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M. and Mofid, V. (2012) Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28, 539-543.
8. Everard, A. and Cani, P.D. (2013) Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 27, 73-83.
9. Fanning, S., Hall, L.G., Cronin, M., Zomer, A., MacSharry, J., Goulding, D., Motherway, M.O., Shanahan, F. et al. (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA 109, 2108-2113.
10. Gomes, A.C., Bueno, A.A., de Souza, R.G.M. and Mota, J.F. (2014) Gut microbiota, probiotics and diabetes. Nutr J 13, 60.
11. Hartemink, R., Kok, B.J., Weenk, G.H. and Rombouts, F.M. (1996) Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J Microbiol Methods 27, 33-43.
12. Hatanaka, T., Inoue, Y., Arima, J., Kumagai, Y., Usuki, H., Kawakami, K., Kimura, M. and Mukaihara, T. (2012) Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran. Food Chem 134, 797-802.
13. Imamura, K., Tsuyama, Y. and Hirata, T. (2011) Identification and characterization of a novel fermented substance produced by edible Aspergillus oryzae AO-1 that inhibits DPP-IV activity. J Biosci Bioeng 111, 37-40.
14. Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A. et al. (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35, 1364-1379.
15. Kim, S.H., Huh, C.S., Choi, I.D., Jeong, J.W., Ku, H.K., Ra, J.H., Kim, T.Y., Kim, G.B. et al. (2014) The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo. J Appl Microbiol 117, 834-845.
16. Lacroix, I.M.E. and Li-Chan, E.C.Y. (2012) Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int Dairy J 25, 97-102.
17. Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
18. Li-Chan, E.C.Y., Huang, S.L., Jao, C.L., Ho, K.P. and Hsu, K.C. (2012) Peptides derived from Atlantic salmon skin gelatin as dipeptidylpeptidase IV inhibitors. J Agric Food Chem 60, 973-978.
19. Mazziotti, G., Gazzaruso, C. and Giustina, A. (2011) Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab 22, 499-506.
20. Miyoshi, M., Ogawa, A., Higurashi, S. and Kadooka, Y. (2014) Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 53, 599-606.
21. Mochida, T., Hira, T. and Hara, H. (2010) The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 151, 3095-3104.
22. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C. et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
23. Nongonierma, A.B. and FitzGerald, R.J. (2013) Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides. J Funct Foods 5, 1909-1917.
24. Panwar, H., Calderwood, D., Grant, I.R., Grover, S. and Green, B.D. (2014) Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha-and beta-glucosidases suggesting anti-diabetic potential. Eur J Nutr 53, 1465-1474.
25. Panwar, H., Calderwood, D., Grant, I.R., Grover, S. and Green, B.D. (2015) Lactobacilli possess inhibitory activity against dipeptidyl peptidase-4 (DPP-4). Ann Microbiol. doi:10.1007/s13213-015-1129-7.
26. Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I. et al. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521.
27. Razmpoosh, E., Javadi, M., Ejtahed, H.S. and Mirmiran, P. (2015) Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes Metab Res Rav. doi:10.1002/dmrr.2665.
28. Reimer, N.K., Holst, J.J. and Ahren, B. (2002) Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol 146, 717-727.
29. Russell, D.A., Ross, R.P., Fitzgerald, G.F. and Stanton, C. (2011) Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 149, 88-105.
30. Sanders, M.E. (2003) Probiotics: considerations for human health. Nutr Rev 61, 91-99.
31. Silveira, S.T., Martínez-Maqueda, D., Recio, I. and Hernández-Ledesma, B. (2013) Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem 141, 1072-1077.
32. Silvi, S., Rumney, C.J. and Rowland, I.R. (1996) An assessment of three selective media for bifidobacteria in faeces. J Appl Bacteriol 81, 561-564.
33. Tulipano, G., Cocchi, D. and Caroli, A.M. (2012) Comparison of goat and sheep β-lactoglobulin to bovine β-lactoglobulin as potential source of dipeptidyl peptidase IV (DPP-4) inhibitors. Int Dairy J 24, 97-101.
34. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
35. Umezawa, H. (1984) Studies on low molecular weight immunomodifiers produced by microorganisms: results of ten years effort. Clin Infect Dis 6, 412-420.
36. Zeng, Z., Luo, J.Y., Zuo, F.L., Zhang, Y., Ma, H.Q. and Chen, S.W. (2015) Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and ?-glucosidase inhibitory activity. J Funct Foods 20, 486-495.
37. Zhang, Y., Chen, R., Ma, H.Q. and Chen, S.W. (2015) Isolation and identification of dipeptidyl peptidase IV-Inhibitory peptides from trypsin/chymotrypsin-treated goat milk casein hydrolysates by 2D-TLC and LC-MS/MS. J Agric Food Chem 63, 8819-8828.
38. Zuo, F.L., Yu, R., Feng, X.J., Chen, L.L., Zeng, Z., Khaskheli, G.B., Ma, H.Q. and Chen, S.W. (2015) Characterization and in vitro properties of potential probiotic Bifidobacterium strains isolated from breast-fed infant feces. Ann Microbiol. doi:10.1007/s13213-015-1187-x.